Spiegel Online manager magazin online

Freitag, 26. Mai 2017

Börse

BUSINESS WIRE: US Food and Drug Administration (FDA) Begins Scientific Review of Philip Morris International's Modified Risk Tobacco Product Application for its Electronically Heated Tobacco Product (EHTP)

25.05.2017, 15:51 Uhr

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

LAUSANNE, Switzerland --(BUSINESS WIRE)-- 25.05.2017 --

On May 24, 2017, the US FDA published the executive summary and research summaries supporting Philip Morris International Inc.'s (PMI) (NYSE/Euronext Paris: PM) Modified Risk Tobacco Product (MRTP) application for the company's EHTP. In doing so, the agency announced that it will publish a notice in the Federal Register establishing a formal docket for public comments on PMI's application at a later date.

PMI submitted the application to the FDA on December 5, 2016.

Publication of PMI's summaries initiates a substantive scientific review process by the FDA's Center for Tobacco Products.

The FDA has made PMI's application summaries publicly available here. The agency will publish additional modules of PMI's MRTP application on a rolling basis. The FDA has established a one-year timetable for reviewing MRTP applications. However, that timing is non-binding.

Anzeige

"We welcome FDA and public review of the comprehensive scientific evidence package that we submitted to the agency through its MRTP application process," said Dr. Moira Gilchrist, PMI Vice President Corporate Affairs of Reduced-Risk Products. "PMI's application demonstrates our commitment to develop innovative, smoke-free technologies that can ultimately replace combustible cigarettes to the benefit of smokers, public health and society at large."

Interested members of the scientific and public health communities can find more information on PMI's EHTP at: PMIScienceUSA.com.

About Philip Morris International Inc. ("PMI")

PMI is the world's leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of reduced-risk products ("RRPs"). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see www.pmi.com and www.pmiscience.com.

Media enquiries
Philip Morris International
Media Office
T: +41 (0)58 242 4500
E: media@pmi.com

Stand: 11.12 Uhr
104,92 Aktueller Kurs an Börse Frankfurt +0,60% / +0,63 Differenz zum Vortag zum Porträt zum Chart

Weitere Nachrichten

25.05. BUSINESS WIRE: US Food and Drug Administration (FDA) Begins Scientific Review of Philip Morris International’s Modified Risk Tobacco Product Application for its Electronically Heated Tobacco Product (EHTP)
25.05. IRW-PRESS: BlueOcean NutraSciences Inc. : BlueOcean NutraSciences meldet exklusives kanadisches Vertriebsabkommen mit Nutrition Excellence
25.05. IRW-PRESS: ALX Uranium Corp.: ALX Uranium Corp. schließt geophysikalische Messung bei Newnham Lake im Athabasca-Becken, Saskatchewan ab
25.05. BUSINESS WIRE: Watch BizWireTV as LinkedIn Shows the World Where They Want to Work with a Ranking of Companies and Amazon Charts Readers Favorite Books
25.05. IRW-PRESS: Aguia Resources Limited: Aguia Resources Limited: Südöstliche Explorationszone TRÊS ESTRADAS liefert wichtige Durchschneidungen
25.05. DGAP-News: ROK Stars kündigt neues Etikettendesign und neue Verschlüsse für Bogart's Gin, Rum und Vodka an
25.05. DGAP-News: Deutsche Rohstoff AG: Tin International unterzeichnet Joint Venture Vertrag mit Lithium Australia
25.05. BUSINESS WIRE: APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market
25.05. IRW-PRESS: ROCKCLIFF COPPER CORPORATION: Rockcliff Copper Corporation: Weitere hochgradige Goldvorkommen im Projekt Snow Lake dokumentiert - vollständig genehmigtes Sommer-Explorationsprogramm wird eingeleitet
25.05. BUSINESS WIRE: Fabric Genomics arbeitet mit europäischem Service-Provider ITTM an Lieferung sicherer Genomanalysen in Europa
Anzeige
Anzeige